These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8793522)

  • 41. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP; Rymer J; Robinson J; Fogelman I
    Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular leiomyoma mimicking endometrial stromal neoplasm in association with GnRH agonist goserelin.
    McCluggage WG; Bharucha H
    Histopathology; 1999 Feb; 34(2):184-6. PubMed ID: 10064405
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hysteroscopic ablation of the endometrium in cases of dysfunctional uterine bleeding--advantage of preparations including zoladex].
    Tiufekchieva E; Nikolov A
    Akush Ginekol (Sofiia); 2002; 41(2):30-4. PubMed ID: 12066549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence.
    Fedele L; Vercellini P; Bianchi S; Brioschi D; Dorta M
    Br J Obstet Gynaecol; 1990 May; 97(5):393-6. PubMed ID: 2115379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical uses of goserelin in gynecologic diseases and its safety].
    Tan SJ; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):58-60. PubMed ID: 10682460
    [No Abstract]   [Full Text] [Related]  

  • 47. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laparoscopic uterine artery bipolar coagulation plus myomectomy vs traditional laparoscopic myomectomy for "large" uterine fibroids: comparison of clinical efficacy.
    Ciavattini A; Clemente N; Delli Carpini G; Saccardi C; Borgato S; Litta P
    Arch Gynecol Obstet; 2017 Dec; 296(6):1167-1173. PubMed ID: 28956149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
    Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study.
    Donnez J; Vilos G; Gannon MJ; Stampe-Sorensen S; Klinte I; Miller RM
    Fertil Steril; 1997 Jul; 68(1):29-36. PubMed ID: 9207580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of goserelin administration before myomectomy on plasma homocysteine levels in patients with symptomatic uterine leiomyomata.
    Celik H; Ayar A; Kilic N
    Fertil Steril; 2003 Oct; 80(4):1060-1. PubMed ID: 14556836
    [No Abstract]   [Full Text] [Related]  

  • 53. Fibroid growth and medical options for treatment.
    Chabbert-Buffet N; Esber N; Bouchard P
    Fertil Steril; 2014 Sep; 102(3):630-9. PubMed ID: 25171950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A comparative study of the effect of Zoladex treatment versus orchiectomy in patients with advanced prostatic cancer].
    Tsvetkov M; Kumanov Kh; Milkov V; Mladenov D; Neĭkov K
    Khirurgiia (Sofiia); 1996; 49(1):5-8. PubMed ID: 8975090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.
    Donnez J; Hervais Vivancos B; Kudela M; Audebert A; Jadoul P
    Fertil Steril; 2003 Jun; 79(6):1380-9. PubMed ID: 12798886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Value of premedication with gonadotropin releasing hormone agonists before transcervical resection of solitary submucous myoma].
    Römer T
    Gynakol Geburtshilfliche Rundsch; 1996; 36(4):194-6. PubMed ID: 9206552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids.
    Zreik TG; Rutherford TJ; Palter SF; Troiano RN; Williams E; Brown JM; Olive DL
    J Am Assoc Gynecol Laparosc; 1998 Feb; 5(1):33-8. PubMed ID: 9454874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study.
    Ginsburg ES; Benson CB; Garfield JM; Gleason RE; Friedman AJ
    Fertil Steril; 1993 Dec; 60(6):956-62. PubMed ID: 8243699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroids (uterine myomatosis, leiomyomas).
    Lethaby A; Vollenhoven B
    Clin Evid; 2004 Dec; (12):2563-85. PubMed ID: 15865807
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibroids (uterine myomatosis, leiomyomas).
    Lethaby A; Vollenhoven B
    Clin Evid; 2005 Dec; (14):2264-82. PubMed ID: 16620489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.